determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …

D-dimer is a soluble fibrin degradation product that results from ordered breakdown of
thrombi by the fibrinolytic system. Numerous studies have shown that D-dimer serves as a …

Deep vein thrombosis and pulmonary embolism, collectively referred to as venous
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …

Importance D-dimer measurement is an important step in the diagnostic strategy of clinically
suspected acute pulmonary embolism (PE), but its clinical usefulness is limited in elderly …

D‐dimer is an indirect marker of fibrinolysis and fibrin turnover; this molecule exhibits unique
properties as a biological marker of hemostatic abnormalities as well as an indicator of …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

D‐dimer assays are commonly used in clinical practice to exclude a diagnosis of deep vein
thrombosis or pulmonary embolism. More recently, they have been also been used to guide …

Background Objective testing for DVT is crucial because clinical assessment alone is
unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the …

The risk of venous thromboembolism (VTE) is increased in cancer patients. To improve
prediction of VTE in cancer patients, we performed a prospective and observational cohort …

D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …